SCHEMBL2431135

SCHEMBL2431135

COc1c(C)ccc(C)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.45
MAPK1 P28482 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ACHE P22303 4/20 0.41
TUBB1 Q9H4B7 2/20 0.40
CA9 Q16790 3/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39
CA14 Q9ULX7 2/20 0.39
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30192941 1.00 ALDH1A1 (0.45) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE
SCHEMBL7784319 0.86 ALDH1A1 (0.36) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE
SCHEMBL29767819 0.86 ALDH1A1 (0.46) ALDH1A1KDM4ESMN1; SMN2ACHETUBB1
SCHEMBL1226775 0.86 ALDH1A1 (0.46) ALDH1A1KDM4ESMN1; SMN2ACHETUBB1
SCHEMBL146614 0.84 ALDH1A1 (0.39) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE
SCHEMBL15315856 0.84 KDM4E (0.52) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE
SCHEMBL30968870 0.84 ALDH1A1 (0.39) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE
SCHEMBL4922559 0.84 CA2 (0.44) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE
SCHEMBL4294248 0.84 MAOA (0.44) TUBB1CA9CA12CA1CA2
SCHEMBL9420335 0.84 ALDH1A1 (0.35) ALDH1A1KDM4EMAPK1SMN1; SMN2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-1093551-A None JP disclosed
JP-1275618-A None JP disclosed
JP-3207714-A None JP disclosed
JP-58099144-A None JP disclosed
JP-6116369-A None JP disclosed
JP-7278260-A None JP disclosed
WO-2026105609-A1 COMPOSITION, LAMINATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE 東レ株式会社 2026-05-21 WO disclosed
US-20260055256-A1 RESIN COMPOSITION, ELECTRONIC COMPONENT DEVICE AND METHOD OF PRODUCING ELECTRONIC COMPONENT DEVICE RESONAC CORP (JP) 2026-02-26 US disclosed
US-12540242-B2 Epoxy resin composition, cured product, and electrical or electronic component MITSUBISHI CHEMICAL CORPORATION (JP) 2026-02-03 US disclosed
US-20250340732-A1 MOLDING RESIN COMPOSITION AND ELECTRONIC COMPONENT DEVICE RESONAC CORPORATION (JP) 2025-11-06 US disclosed
EP-0360461-A2 Resin compositions for sealing semiconductors MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-03-28 EP disclosed
EP-0359500-A2 Resin compositions for sealing semiconductors MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-03-21 EP disclosed
JP-H01275618-A EPOXY RESIN COMPOSITION MITSUI TOATSU CHEM INC 1989-11-06 JP disclosed
JP-H0193551-A DIHYDRIC PHENOLARALKYL RESIN AND PRODUCTION THEREOF MITSUI TOATSU CHEM INC 1989-04-12 JP disclosed
EP-0310126-A2 Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines F. HOFFMANN-LA ROCHE AG (CH) 1989-04-05 EP disclosed
JP-S5899144-A BASE CEMENT FOR BULB TOSHIBA CORP 1983-06-13 JP disclosed
US-4340700-A Process for preparing a phenolic resin from an aralkylene ether and an aromatic aldehyde ALBRIGHT & WILSON LIMITED (GB) 1982-07-20 US disclosed
EP-0004794-B1 SUBSTITUTED BENZAZEPINES, PROCESSES FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITHKLINE BECKMAN CORPORATION (US) 1982-04-28 EP disclosed
EP-0004794-A2 Substituted benzazepines, processes for preparing them and pharmaceutical compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1979-10-17 EP disclosed
US-4171359-A DOPAMINERGIC ACTIVITY SMITHKLINE CORPORATION (US) 1979-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260055256-A1 RESIN COMPOSITION, ELECTRONIC COMPONENT DEVICE AND METHOD OF PRODUCING ELECTRONIC COMPONENT DEVICE GJA1, GJB2, EED ALDH1A1 982/4885KDM4E 596/4885MAPK1 1132/4885
US-12540242-B2 Epoxy resin composition, cured product, and electrical or electronic component RER1, ARCN1, SEM1 ALDH1A1 354/4885KDM4E 1252/4885MAPK1 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.